WO2003064394A8 - 5-ring heterocycles used as antiviral agents - Google Patents
5-ring heterocycles used as antiviral agentsInfo
- Publication number
- WO2003064394A8 WO2003064394A8 PCT/EP2003/000376 EP0300376W WO03064394A8 WO 2003064394 A8 WO2003064394 A8 WO 2003064394A8 EP 0300376 W EP0300376 W EP 0300376W WO 03064394 A8 WO03064394 A8 WO 03064394A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antiviral agents
- ring heterocycles
- heterocycles used
- production
- medicines used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002474456A CA2474456A1 (en) | 2002-01-28 | 2003-01-16 | 5-ring heterocycles used as antiviral agents |
JP2003564017A JP2005521669A (en) | 2002-01-28 | 2003-01-16 | 5-membered heterocycles for use as antiviral agents |
EP03734671A EP1472229A1 (en) | 2002-01-28 | 2003-01-16 | 5-ring heterocycles used as antiviral agents |
AU2003239243A AU2003239243A1 (en) | 2002-01-28 | 2003-01-16 | 5-ring heterocycles used as antiviral agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10203086A DE10203086A1 (en) | 2002-01-28 | 2002-01-28 | 5-ring heterocycles |
DE10203086.3 | 2002-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003064394A1 WO2003064394A1 (en) | 2003-08-07 |
WO2003064394A8 true WO2003064394A8 (en) | 2003-12-24 |
Family
ID=7713161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/000376 WO2003064394A1 (en) | 2002-01-28 | 2003-01-16 | 5-ring heterocycles used as antiviral agents |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1472229A1 (en) |
JP (1) | JP2005521669A (en) |
AU (1) | AU2003239243A1 (en) |
CA (1) | CA2474456A1 (en) |
DE (1) | DE10203086A1 (en) |
WO (1) | WO2003064394A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8124782B2 (en) * | 2004-09-29 | 2012-02-28 | Bayer Pharma Aktiengesellschaft | Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide |
EP2958897B1 (en) * | 2013-02-19 | 2019-01-09 | Senomyx, Inc. | Compounds useful as modulators of trpm8 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8101067A1 (en) * | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Benzimidazoles, their preparation and pharmaceutical compositions containing them. |
CA2240111A1 (en) * | 1995-12-14 | 1997-06-19 | Wallace T. Ashton | Antagonists of gonadotropin releasing hormone |
DK1043995T3 (en) * | 1997-12-22 | 2007-03-05 | Bayer Pharmaceuticals Corp | Inhibition of p38 kinase activity using aryl- and heteroaryl-substituted heterocyclic ureas |
-
2002
- 2002-01-28 DE DE10203086A patent/DE10203086A1/en not_active Withdrawn
-
2003
- 2003-01-16 WO PCT/EP2003/000376 patent/WO2003064394A1/en active Application Filing
- 2003-01-16 JP JP2003564017A patent/JP2005521669A/en active Pending
- 2003-01-16 EP EP03734671A patent/EP1472229A1/en not_active Withdrawn
- 2003-01-16 AU AU2003239243A patent/AU2003239243A1/en not_active Abandoned
- 2003-01-16 CA CA002474456A patent/CA2474456A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2474456A1 (en) | 2003-08-07 |
EP1472229A1 (en) | 2004-11-03 |
AU2003239243A1 (en) | 2003-09-02 |
DE10203086A1 (en) | 2003-07-31 |
JP2005521669A (en) | 2005-07-21 |
WO2003064394A1 (en) | 2003-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300933I2 (en) | Letermovir | |
WO2005063734A3 (en) | Substituted thiophenes | |
WO2003080582A3 (en) | Fredericamycin derivatives | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
AU2003285091A1 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
WO2005039504A3 (en) | Compounds and methods for treating toll-like receptor 2-related diseases and conditions | |
NO20035025L (en) | Use of osteopontin for the treatment and / or prevention of neurological diseases, as well as a pharmaceutical composition comprising osteopontin or an antagonist with osteopontin activity. | |
WO2004071382A3 (en) | Substituted heterocycles | |
ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
HK1093729A1 (en) | Substituted quinolones | |
WO2006089664A3 (en) | Heterocyclylamide-substituted imidazoles | |
CA2474510A1 (en) | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders | |
AU2003258145A8 (en) | Substituted phenylindoles for the treatment of hiv | |
IL163951A (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
WO2003033557A3 (en) | Copolymers containing fluorine, method for the production and use thereof | |
NO20033318L (en) | 2H-1-benzopyran derivatives, process of manufacture, and pharmaceutical compositions thereof | |
AU2002319296A1 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with CGMP regulated processes | |
AU2003303217A1 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
AU2003289652A1 (en) | The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion | |
WO2005047278A3 (en) | Substituted dihydroquinazolines ii | |
WO2003064394A8 (en) | 5-ring heterocycles used as antiviral agents | |
EP1469844A4 (en) | Method and compound for the prophylaxis or treatment of an immunodeficiency condition, such as aids | |
WO2003024996A3 (en) | Antibacterial macrocycles | |
AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases | |
WO2004112690A3 (en) | 2-aminobenzoyl derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 32/2003 ADD "DECLARATION UNDER RULE 4.17: - AS TO APPLICANT?S ENTITLEMENT TO APPLY FOR AND BE GRANTED A PATENT (RULE 4.17(II))." |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003734671 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2474456 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003564017 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003734671 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |